The efficiency frontier approach to economic evaluation of health-care interventions
- PMID: 20575151
- DOI: 10.1002/hec.1629
The efficiency frontier approach to economic evaluation of health-care interventions
Abstract
Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system.
Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system.
Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.
Comment in
-
The efficiency frontier approach to economic evaluation: will it help German policy making?Health Econ. 2010 Oct;19(10):1128-31. doi: 10.1002/hec.1644. Health Econ. 2010. PMID: 20641141 No abstract available.
-
Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods.Health Econ. 2010 Oct;19(10):1132-6. doi: 10.1002/hec.1645. Health Econ. 2010. PMID: 20662107 No abstract available.
Similar articles
-
The efficiency frontier approach to economic evaluation: will it help German policy making?Health Econ. 2010 Oct;19(10):1128-31. doi: 10.1002/hec.1644. Health Econ. 2010. PMID: 20641141 No abstract available.
-
Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach.Health Econ. 2010 Oct;19(10):1139-41. doi: 10.1002/hec.1657. Health Econ. 2010. PMID: 20842682 No abstract available.
-
IQWiG methods--a response to two critiques.Health Econ. 2010 Oct;19(10):1137-8. doi: 10.1002/hec.1658. Health Econ. 2010. PMID: 20842681 No abstract available.
-
[Decision-analytical modelling of costs per QALY in the context of the German Social Law].Gesundheitswesen. 2009 Nov;71(11):739-50. doi: 10.1055/s-0029-1220756. Epub 2009 Jun 23. Gesundheitswesen. 2009. PMID: 19551622 Review. German.
-
International standards for health economic evaluation with a focus on the German approach.J Clin Pharm Ther. 2013 Aug;38(4):277-85. doi: 10.1111/jcpt.12043. Epub 2013 Apr 26. J Clin Pharm Ther. 2013. PMID: 23621433 Review.
Cited by
-
Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands.Eur J Health Econ. 2021 Aug;22(6):991-999. doi: 10.1007/s10198-021-01303-2. Epub 2021 Apr 7. Eur J Health Econ. 2021. PMID: 33829344 Free PMC article.
-
Cost per responder of TNF-α therapies in Germany.Clin Rheumatol. 2013 Dec;32(12):1805-9. doi: 10.1007/s10067-013-2332-1. Epub 2013 Jul 23. Clin Rheumatol. 2013. PMID: 23877487 Free PMC article.
-
Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study.EClinicalMedicine. 2024 Jul 28;74:102743. doi: 10.1016/j.eclinm.2024.102743. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39764179 Free PMC article.
-
A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation.Patient. 2012;5(1):45-56. doi: 10.2165/11587140-000000000-00000. Patient. 2012. PMID: 22185216
-
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers.Health Econ. 2015 Apr;24(4):481-90. doi: 10.1002/hec.3041. Epub 2014 Mar 4. Health Econ. 2015. PMID: 24590819 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources